Position
Chief Medical Officer
Company
IMUNON
Description
IMUNON, Inc has announced the appointment of Dr. Douglas V Faller, MD, PhD, as chief medical officer. Dr Faller will lead the company’s clinical strategy, specifically focusing on advancing its lead program IMNN-001 for the treatment of newly diagnosed advanced ovarian cancer.
Quick answer
IMUNON Appoints Dr. Douglas V. Faller as Chief Medical Officer (February 10, 2025). IMUNON is based in Lawrenceville, New Jersey, United States.
- Who is the new Chief Medical Officer at IMUNON?
- IMUNON named Douglas V. Faller Chief Medical Officer, announced February 10, 2025.
- What did IMUNON announce on February 10, 2025?
- IMUNON, Inc has announced the appointment of Dr. Douglas V Faller, MD, PhD, as chief medical officer. Dr Faller will lead the company’s clinical strategy, specifically focusing on advancing its lead program IMNN-001 for the treatment of newly diagnosed advanced ovarian cancer.
- What does IMUNON do?
- IMUNON is a clinical-stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the body’s natural mechanisms to generate safe, effective and durable responses across a broad...
- Where is IMUNON based?
- IMUNON is based in Lawrenceville, New Jersey, United States.
- Which similar companies made leadership changes around the same time?
- Lakewood-Amedex, Inc. (February 12, 2025), Sonnet BioTherapeutics Holdings (February 13, 2025), Terns Pharmaceuticals (February 25, 2025) and Climb Bio, Inc. (February 25, 2025) also announced leadership changes within 45 days of IMUNON.
Source: Fundz verified event record.
Other recent leadership changes in Healthcare and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Kelvin Cooper, Ph.D., C.Chem., FRSC, Elevated to Chief Executive Officer and Peter Ceccacci Promoted to Chief Financial Officer at Lakewood-Amedex Inc. (February 12, 2025)
- Sonnet BioTherapeutics Appoints Stephen J. McAndrew, Ph.D., as Chief Business Officer (February 13, 2025)
- Terns Pharmaceuticals Appoints Andrew Gengos as Chief Financial Officer (February 25, 2025)
- Climb Bio Appoints Perrin Wilson, Ph.D., as Chief Business Officer (February 25, 2025)
- Dr. Anh Nguyen Appointed as Xeris' Chief Medical Officer succeeding Ken Johnson PharmD, SVP, Global Development and Medical Affairs (February 25, 2025)
- Crinetics Pharmaceuticals Appoints Tobin “Toby” Schilke as Chief Financial Officer (February 26, 2025)
Who to call at IMUNON, and when
A new leader at IMUNON brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day IMUNON raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at IMUNON, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at IMUNON. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment IMUNON changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
IMUNON changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.